First Mercantile Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

First Mercantile Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-297	Closed	-$53K	–	862
2021 Q2	$53K	Sell	297 -27	-8%	-$4.68K	0.01%	793
2021 Q1	$53K	Sell	324 -30	-8%	-$4.94K	0.01%	773
2020 Q4	$58K	Sell	354 -40	-10%	-$5.96K	0.01%	773
2020 Q3	$58K	Sell	394 -84	-18%	-$10.4K	0.01%	771
2020 Q2	$53K	Sell	478 -25	-5%	-$2.77K	0.01%	773
2020 Q1	$50K	Buy	503 +55	+12%	+$7.11K	0.01%	701
2019 Q4	$67K	Buy	+448	New	+$61K	0.01%	758
2013 Q4	–	Sell	-515	Closed	-$47K	–	1168
2013 Q3	$47K	Sell	515 -300	-37%	-$24.2K	﹤0.01%	985
2013 Q2	$56K	Buy	+815	New	+$49.8K	﹤0.01%	938

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

First Mercantile Trust's JAZZ Position: Q3 2021 in Review

First Mercantile Trust sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 297 shares — an estimated $53K sold.

First Mercantile Trust first reported a position in JAZZ in Q2 2013 and held it in 9 quarters. The position peaked at $67K in Q4 2019. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

First Mercantile Trust reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
First Mercantile Trust sold 297 Jazz Pharmaceuticals shares in Q3 2021, an estimated $53K.
First Mercantile Trust first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 9 quarters.
First Mercantile Trust's Jazz Pharmaceuticals position peaked at $67K in Q4 2019.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.